Boston Scientific BSX shares are trading lower on Thursday.
The company announced it has commenced concurrent offerings of $750 million shares of its common stock and $750 million of shares of its Series A Mandatory Convertible Preferred Stock.
Boston Scientific produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract tests, interventional oncology, and treatment of incontinence.
Boston Scientific shares were trading down 5.9% to $34.98 at time of publication on Thursday. The stock has a 52-week high of $46.62 and a 52-week low of $24.10.
Related Links:
Varian Will Acquire Embolic Bead Asset From Boston Scientific
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.